A Case Report on Tamaka Shwasa
DOI:
https://doi.org/10.70066/jahm.v11i4.781Keywords:
Tamaka Shwasa , Bronchial Asthma, Bharangi Churna, Sunthi ChurnaAbstract
Tamaka Shwasa may be correlated with Bronchial Asthma on the basis of its features & Etiopathogenesis. It is considered as Yapya (palliable) because this type of Shwasa roga is not only difficult to treat but also has a repetitive nature. In India bronchial asthma is major health problem and hyperventilation, cold air, tobacco smoke, dust, respiratory viral infections, emotional stress, aspirin, beta blockers are some of the trigging factors. The prevalence of Bronchial Asthma is about 300 million cases around the globe, and found in approximately 10% of children and youth below 18 years of age. The current statistical data reveals that the prevalence of Bronchial Asthma in the Middle East region is somewhat lower, varying between 5.6% in Saudi Arabia and 8.5% in Kuwait. In Iraq, approximately 200,000 patients per year with asthma are either hospitalized or treated in an Emergency room[1].
It is the need of the hour to find out a cost effective, therapeutically efficacious and safe herbal remedy for the management of bronchial asthma vis-à-vis Tamaka Shwasa. Keeping this in view the present study has been taken up and tried with a single drug Bharangi (Clerodendrum serratum) in the form of powder in a dose of 3 gms. after adding with equal amount of Sunthi (Zingiber officinalis) and administered internally with hot water twice a day after food and the results are encouraging.
Additional Files
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Vd.Sonali Sharma

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Authors retain the copyright of their work and grant the Journal of Ayurveda and Holistic Medicine (JAHM) the right of first publication. All published articles are licensed under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) license, which permits non-commercial sharing, use, distribution, and adaptation with proper attribution and the same license terms.
JAHM ensures free, irrevocable, worldwide access to its content. Users may copy, distribute, display, and share published works for non-commercial purposes with appropriate credit to the author(s) and the journal. Limited printed copies for personal, non-commercial use are allowed under the same license.
If a submission is not accepted for publication, the author(s) will be notified.
By submitting, authors confirm that the work is original, that all listed authors have contributed and approved it, and that it does not infringe any third-party rights or duplicate work submitted elsewhere.